109 related articles for article (PubMed ID: 22377784)
1. Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome.
Goodison WV; Frisardi V; Kehoe PG
J Alzheimers Dis; 2012; 30 Suppl 2():S269-82. PubMed ID: 22377784
[TBL] [Abstract][Full Text] [Related]
2. Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.
Yu JT; Chang RC; Tan L
Prog Neurobiol; 2009 Nov; 89(3):240-55. PubMed ID: 19664678
[TBL] [Abstract][Full Text] [Related]
3. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.
Lopez JR; Lyckman A; Oddo S; Laferla FM; Querfurth HW; Shtifman A
J Neurochem; 2008 Apr; 105(1):262-71. PubMed ID: 18021291
[TBL] [Abstract][Full Text] [Related]
4. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
Alcocer L; Bendersky M; Acosta J; Urina-Triana M
Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
[TBL] [Abstract][Full Text] [Related]
5. Calcium dysregulation in Alzheimer's disease.
Bojarski L; Herms J; Kuznicki J
Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease pathogenesis and therapeutic interventions.
Parihar MS; Hemnani T
J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
8. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
Opie LH; Yusuf S; Kübler W
Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
[TBL] [Abstract][Full Text] [Related]
9. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
10. What to look for beyond "pathogenic" factors in senile dementia? A functional deficiency of Ca²⁺ signaling.
Chen M; Nguyen HT; Sawmiller DR
J Alzheimers Dis; 2011; 27(4):679-89. PubMed ID: 21876251
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
12. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
Kawahara M; Negishi-Kato M; Sadakane Y
Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
[TBL] [Abstract][Full Text] [Related]
13. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
14. Use of calcium channel blockers for glaucoma.
Araie M; Mayama C
Prog Retin Eye Res; 2011 Jan; 30(1):54-71. PubMed ID: 20933604
[TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. [Calcium channel blockers in the treatment of cardiovascular disease].
Halawa B
Pol Merkur Lekarski; 2001 Jul; 11(61):83-7. PubMed ID: 11579840
[TBL] [Abstract][Full Text] [Related]
18. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
19. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.
Ríos JA; Cisternas P; Arrese M; Barja S; Inestrosa NC
Prog Neurobiol; 2014 Oct; 121():125-46. PubMed ID: 25084549
[TBL] [Abstract][Full Text] [Related]
20. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
